Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹839.30
Market cap: ₹15,033 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.1×Sector 50.4×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Capital Structure Change 3 Fund Raise 2 Financial Results 2 Board Meeting Date 2 Other Announcement 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 14:13 IST NSE

Financial Results

Natco Pharma Q1 FY27 Results: Net Profit ₹206.5 Cr, Down 57.0% YoY

Natco Pharma Ltd reported revenue from operations of ₹735.2 Cr (-44.7% YoY) and net profit of ₹206.5 Cr (-57.0% YoY) for Q1 FY27.

Key figure: Net profit ₹206.5 Cr · -57.0% YoY

Open full results → Read the filing ↗

29 May 2026 14:18 IST BSE

Financial Results

Natco Pharma Q4 FY26 Results: Net Profit ₹269 Cr, Down 33.7% YoY

Natco Pharma Ltd reported revenue from operations of ₹739.1 Cr (-39.5% YoY) and net profit of ₹269 Cr (-33.7% YoY) for Q4 FY26.

Key figure: Net profit ₹269 Cr · -33.7% YoY

Open full results → Read the filing ↗